Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/learnout/public_html/podcaststream/listen.php on line 894
- Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances(Sat, May 03, 2025)
";
- Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies(Mon, Apr 28, 2025)
";
- Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies(Tue, Apr 22, 2025)
";
- Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2(Fri, Apr 18, 2025)
";
- Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting(Tue, Apr 15, 2025)
";
- Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit(Sat, Apr 12, 2025)
";
- Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences(Fri, Apr 04, 2025)
";
- Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses(Mon, Mar 24, 2025)
";
- Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1(Tue, Mar 18, 2025)
";
- Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies(Tue, Feb 25, 2025)
";
- Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy(Wed, Feb 19, 2025)
";
- Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani(Tue, Feb 11, 2025)
";
- Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series(Thu, Jan 30, 2025)
";
- Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia(Thu, Jan 23, 2025)
";
- CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series(Thu, Jan 16, 2025)
";
- Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series(Tue, Jan 14, 2025)
";
- Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series(Thu, Jan 09, 2025)
";
- Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series(Tue, Jan 07, 2025)
";
- Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series(Fri, Dec 20, 2024)
";
- Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series(Thu, Dec 19, 2024)
";
- Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis(Tue, Dec 17, 2024)
";
- Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes(Fri, Dec 13, 2024)
";
- Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria(Wed, Dec 04, 2024)
";
- Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Multiple Myeloma(Tue, Nov 26, 2024)
";
- Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series(Fri, Nov 22, 2024)
";
- Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia(Wed, Nov 20, 2024)
";
- What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma(Fri, Nov 08, 2024)
";
- Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma(Wed, Oct 30, 2024)
";
- Practical Perspectives: Current Management of Chronic Myeloid Leukemia(Thu, Oct 24, 2024)
";
- Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma(Thu, Oct 17, 2024)
";
- Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series(Thu, Oct 10, 2024)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma(Mon, Aug 12, 2024)
";
- RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma(Fri, Jul 12, 2024)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis(Tue, Jul 02, 2024)
";
- Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences(Wed, May 29, 2024)
";
- Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Tue, May 28, 2024)
";
- Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma(Fri, May 24, 2024)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia(Tue, May 14, 2024)
";
- Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series(Thu, May 02, 2024)
";
- Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria(Fri, Apr 26, 2024)
";
- Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences(Wed, Apr 24, 2024)
";
- Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences(Fri, Apr 12, 2024)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma(Wed, Mar 27, 2024)
";
- Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series(Fri, Mar 08, 2024)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia(Tue, Feb 27, 2024)
";
- Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series(Wed, Jan 17, 2024)
";
- Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series(Fri, Nov 10, 2023)
";
- Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series(Fri, Oct 20, 2023)
";
- What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma(Thu, Oct 19, 2023)
";
- Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences(Wed, Oct 18, 2023)
";
- Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar(Thu, Oct 12, 2023)
";
- What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma(Mon, Oct 09, 2023)
";
- Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm(Thu, Oct 05, 2023)
";
- Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma(Thu, Sep 28, 2023)
";
- What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors(Fri, Sep 22, 2023)
";
- Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma(Thu, Sep 14, 2023)
";
- Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma(Thu, Aug 31, 2023)
";
- Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series(Wed, Aug 30, 2023)
";
- Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences(Tue, Aug 29, 2023)
";
- Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management(Wed, Aug 23, 2023)
";
- Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia(Fri, Aug 18, 2023)
";
- Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes(Wed, Aug 02, 2023)
";
- Oncology Today with Dr Neil Love: Immune Thrombocytopenia Edition(Mon, Jul 31, 2023)
";
- Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria(Wed, Jul 26, 2023)
";
- Meet The Professor: The Current and Future Management of Non-Hodgkin Lymphoma(Mon, Jul 10, 2023)
";
- Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series(Fri, Jun 16, 2023)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes(Fri, Apr 21, 2023)
";
- Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition(Wed, Apr 19, 2023)
";
- Oncology Today with Dr Neil Love — Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition(Wed, Apr 12, 2023)
";
- Recent Advances and Future Directions in Chronic Lymphocytic Leukemia and Lymphomas — With Dr Danielle Brander and Craig Moskowitz (Proceedings from a Symposium in Partnership with NCOA and SCOS)(Fri, Mar 17, 2023)
";
- Oncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting(Thu, Mar 02, 2023)
";
- Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors(Thu, Feb 23, 2023)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas(Fri, Feb 17, 2023)
";
- Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series(Tue, Feb 14, 2023)
";
- Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting(Thu, Feb 09, 2023)
";
- Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma(Mon, Feb 06, 2023)
";
- Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting(Thu, Feb 02, 2023)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma(Wed, Feb 01, 2023)
";
- Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia(Fri, Jan 20, 2023)
";
- Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 3 of a 4-Part Series(Thu, Jan 19, 2023)
";
- What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia(Fri, Jan 13, 2023)
";
Advertisement
